Premature ovarian failure: Which protocols?;L'insuffisance ovarienne débutante : quels protocoles ?

Gynecologie Obstetrique et Fertilite

Volumn 36, Issue 9, 2008, Pages 872-881

  Merviel, P ^a   Lourdel, E ^a   Boulard, V ^a   Cabry, R ^a   Claeys, C ^a   Olieric M F ^a   Sanguinet, P ^a   Brasseur, F ^a   Henri, I ^a   Copin, H ^a  

^a AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

Assisted Reproductive Techniques (ART); GnRH agonist; GnRH antagonist; Natural cycle; Pregnancy rate; Premature ovarian failure

Indexed keywords

ACETYLSALICYLIC ACID; ANDROGEN; AROMATASE INHIBITOR; CLOMIFENE CITRATE; ETHINYLESTRADIOL PLUS NORGESTREL; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; GONADOTROPIN; GROWTH HORMONE; LETROZOLE; NITRIC OXIDE; PRASTERONE; RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE; TRIPTORELIN;

ADULT; ARTICLE; CLINICAL PROTOCOL; DOSE CALCULATION; DRUG DOSE INCREASE; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; HUMAN; MALE; MENSTRUAL CYCLE; ONSET AGE; OVARY FUNCTION; PREGNANCY RATE; PREMATURE OVARIAN FAILURE; UTERUS FUNCTION;

EID: 50349100007     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/j.gyobfe.2008.06.015     Document Type: Article

References (79)

1. Steptoe P.C., and Edwards R.G. Birth after the reimplantation of a human embryo. Lancet 12 (1978) 366
2. Pelinck M.J., Hoek A., Simon A.H., and Heineman M.J. Efficacy of natural cycle IVF: A review of the literature. Hum Reprod Update 8 (2002) 129-139
3. Janssens R.M., Lambalk C.B., Schats R., and Schoemaker J. Successful in vitro fertilization in a natural cycle after four previously failed attempts in stimulated cycles. Hum Reprod 14 (1999) 2497-2498
4. Olivennes F., and Frydman R. Friendly IVF: the way of the future?. Hum Reprod 13 (1998) 1121-1124
5. Morgia F., Sbracia M., Schimberni M., Giallonardo A., Piscitelli C., Giannini P., et al. A controlled trial of natural cycle versus microdose gonadotrophin-releasing hormone analog flare cycles in poor responders undergoing in vitro fertilization. Fertil Steril 81 (2004) 1542-1547
6. Bassil A., Godin P.A., and Donnez J. Outcome of in vitro fertilization through natural cycles in poor responders. Hum Reprod 14 (1999) 1262-1265
7. Feldman B., Seidman D.S., Levron J., Bider D., Shulman A., Shine S., et al. In vitro fertilization following natural cycles in poor responders. Gynecol Endocrinol 15 (2001) 328-334
8. Castelo-Branco A., Frydman N., Kadoch J., Le Du A., Fernandez H., Fanchin R., et al. The role of the semi natural cycle as option of treatment of patients with a poor prognosis for successful in vitro fertilization. J Gynecol Obstet Biol Reprod 33 (2004) 518-524
9. Reyftmann L., Dechaud H., Loup V., Anahory T., Brunet-Joyeux C., Lacroix N., et al. Natural cycle in vitro fertilization cycle in poor responders. Gynecol Obstet Fertil 35 (2007) 352-358
10. Elizur S.E., Aslan D., Shulman A., Weisz B., Bider D., and Dor J. Modified natural cycle using GnRH antagonist can be optional treatment in poor responders undergoing IVF. J Assist Reprod Genet 22 (2005) 75-79
11. Weghofer A., Margreiter M., Bassim S., Sevelda U., Beilhack E., and Feichtinger W. Minimal stimulation using recombinant follicle-stimulating hormone and a gonadotropin-releasing hormone antagonist in women of advanced age. Fertil Steril 81 (2004) 1002-1006
12. Ben-Rafael Z., Benadiva C.A., Ausmanas M., Barber B., Blasco L., Flickinger G.L., et al. Dose of human menopausal gonadotropin influences the outcome of an in vitro fertilization program. Fertil Steril 48 (1987) 964-968
13. Garcia-Velasco J.A., Isaza V., Requena A., Matinez-Salazar F.J., Landazabal A., Remohi J., et al. High doses of gonadotrophins combined with stop versus non-stop protocol of GnRH analogue administration in low responder IVF patients: a prospective, randomized, controlled trial. Hum Reprod 15 (2000) 2292-2296
14. FIVNAT 2004 : rapport annuel. Laboratoire Organon.
15. Centre for clinical effectiveness. In women labelled as poor responders to ovulation stimulation in an assisted reproduction program, is there evidence for the effectiveness of increasing the total dose of FSH above 3,000 IU? Cochrane Database Syst Rev 2000;HTA-20030660.
16. Khalaf Y., El-Toukhy T., Taylor A., and Braude P. Increasing the gonadotrophin dose in the course of an in vitro fertilization cycle does not rectify an initial poor response. Eur J Obstet Gynecol Reprod Biol 103 (2002) 146-149
17. Cédrin-Durnerin I., Bständig B., Herve F., Wolf J., Uzan M., and Hugues J. A comparative study of high fixed-dose and decremental-dose regimens of gonadotropins in a minidose gonadotropin-releasing hormone agonist flare protocol for poor responders. Fertil Steril 73 (2000) 1055-1056
18. Land J.A., Yarmolinskaya M.I., Dumoulin J.C., and Evers J.L. High-dose human menopausal gonadotrophin stimulation in poor responders does not improve in vitro fertilization outcome. Fertil Steril 65 (1996) 961-965
19. Faber B.M., Mayer J., Cox B., Jones D., Toner J.P., Oehninger S., et al. Cessation of gonadotropin-releasing hormone agonist therapy combined with high-dose gonadotropin stimulation yields favourable pregnancy results in low responders. Fertil Steril 69 (1998) 826-830
20. Khalaf Y., Taylor A., and Braude P. Low serum estradiol concentrations after five days of controlled ovarian hyperstimulation for in vitro fertilization are associated with poor outcome. Fertil Steril 74 (2000) 63-66
21. D'Amato G., Caroppo E., Pasquadibisceglie A., Carone D., Vitti A., and Vizziello G.M. A novel protocol of ovulation induction with delayed gonadotropin-releasing hormone antagonist administration combined with high-dose recombinant follicle-stimulating hormone and clomiphene citrate for poor responders and women over 35 years. Fertil Steril 81 (2004) 1572-1577
22. Goswani S.K., Das T., Chattopadhyay R., Sawhney V., Kumar J., Chaudhury K., et al. A randomized single-blind controlled trial of letrozole as a low cost IVF protocol in women with poor ovarian response: a preliminary report. Hum Reprod 19 (2004) 2031-2035
23. Schoolcraft W.B., Surrey E.S., Minjarez D.A., Stevens J.M., and Gardner D.K. Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist/letrozole protocol?. Fertil Steril 89 (2008) 151-156
24. Palter S.F., Tavares A., Hourvitz A., Veldhuis J.D., and Adashi E.Y. Are estrogen of importance to primate/human ovarian folliculogenesis?. Endocr Rev 22 (2001) 389-424
25. Weissman A., Farhi J., Royburt M., Nahum H., Glezerman M., and Levran D. Prospective evaluation of two stimulation protocols for low responders who were undergoing in vitro fertilization-embryo transfer. Fertil Steril 79 (2003) 886-892
26. Surrey E.S., Bower J.A., Hill D.M., Ramsey J., and Surrey M.W. Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization. Fertil Steril 69 (1998) 419-424
27. Feldberg D., Farmi J., Ashkenazi J., Dicker D., Shalev J., and Ben-Rafael Z. Microdose GnRH agonist is the treatment of choice in poor responders with high FSH levels. Fertil Steril 62 (1994) 343-346
28. Cummins J., Yovich J., Edirisinghe W., and Yovich J. Pituitary down-regulation using leuprolide for the intensive ovulation management of poor prognosis patients having in vitro fertilization treatments. J In Vitro Fert Embryo Transf 6 (1989) 345-352
29. McKenna K., Foster P., McBain J., Martin M., and Johnston W. Combined treatment with gonadotropin-releasing hormone agonist and gonadotropins in poor responders to hyperstimulation for in vitro fertilization (IVF): clinical and endocrine results. Aus NZJ Obstet Gynecol 29 (1989) 428-432
30. Horvath P., Styler M., Hammond J., Shelden R., and Kemmann E. Exogenous gonadotropin requirements are increased in leuprolide suppressed women undergoing ovarian stimulation. Fertil Steril 49 (1988) 159-162
31. Ashrafi M., Ashtiani S.K., Zafarani F., Samani R.O., and Eshrati B. Evaluation of ovulation induction protocols for poor responders undergoing assisted reproduction techniques. Saudi Med J 26 (2005) 593-596
32. Ku S.Y., Choi Y.S., Jee B.C., Suh C.S., Choi Y.M., Kim J.G., et al. A preliminary study on reduced dose (33 or 25 μg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization embryo-transfer. Gynecol Endocrinol 21 (2005) 227-231
33. Olivennes F., Fanchin R., De Ziegler D., and Frydman R. Poor responders: screening and treatment possibilities. J Assist Reprod Genet 10 (1993) 115-117
34. Dirnfeld M., Fruchter O., Yshai D., Lissak A., Ahdut A., and Abramovici H. Cessation of gonadotropin-releasing hormone analogue (GnRH-a) upon down-regulation versus conventional long GnRH-a protocol in poor responders undergoing in vitro fertilization. Fertil Steril 72 (1999) 406-411
35. Pu-Tsui W., Kuo-Kuang L.R., Jin-Tsung S., Jen-Wan H., Ming-Huei L., and Yu-Ming H. Cessation of low dose gonadotropin-releasing hormone agonist therapy combined followed by high-dose gonadotropin stimulation yields a favourable ovarian response in poor responders. J Assist Reprod Genet 19 (2002) 1-6
36. Barri P.N., Coroleu B., Martinez F., and Veiga A. Stimulation protocols for poor responders and aged women. Mol Cell Endocrinol 166 (2000) 15-20
37. Detti L., Williams D.B., Robins J.C., Maxwell R.A., and Thomas M.A. A comparison of three downregulation approaches for poor responders undergoing in vitro fertilization. Fertil Steril 84 (2005) 1401-1405
38. Katayama K., Roesler M., Gunnarson G., Stehlik E., and Jagusch S. Short-term use of gonadotropin-releasing hormone agonist (leuprolide) for in vitro fertilization. J In Vitro Fert Embryo Transfer 5 (1988) 332-337
39. Garcia J., Padilla S., Bargati J., and Baramki T. Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: a better alternative for in vitro fertilization. Fertil Steril 53 (1990) 302-305
40. Karande V., Morris R., Rinehart J., Miller C., Rao R., and Gleicher N. Limited success using the « flare » protocol in poor responders in cycles with low basal follicle-stimulating hormone levels during in vitro fertilization. Fertil Steril 67 (1997) 900-903
41. Ron-El R., Herman A., Golan A., van der Ven H., Caspi E., and Diedrich K. The comparison of early follicular and midluteal administration of long-acting gonadotropin-releasing hormone. Fertil Steril 54 (1990) 233-237
42. Anserini P., Magnasco A., Remorgida V., Gaggero G., Testa D., and Capitanio G. Comparison of a blocking vs a flare-up protocol in poor responders with a normal and abnormal clomiphene citrate challenge test. Gynecol Endocrinol 11 (1997) 321-326
43. San Roman G., Surrey E., Judd H., and Kerin J. A prospective randomized comparison of luteal phase versus concurrent follicular phase initiation of gonadotropin-releasing hormone agonist for in vitro fertilization. Fertil Steril 58 (1992) 744-749
44. Scott R., and Navot D. Enhancement of ovarian responsiveness with microdoses of gonadotropin-releasing hormone agonists during ovulation induction for in vitro fertilization. Fertil Steril 61 (1994) 880-885
45. Yakin K., Kahraman S., Vanlioglu F., Kumtepe Y., and Findikli N. Comparison of microdose and standard doses of GnRH analogue in flare protocols for controlled ovarian hyperstimulation in poor responders. Fertil Steril 76 suppl 1 (2000) 337
46. Patton P.E., Eaton D., Burry K.A., and Wolf D.P. The use of gonadotropin-releasing hormone agonist to regulate oocyte retrieval time. Fertil Steril 54 (1990) 652-655
47. Biljan M., Mahutte N., Dean N., Hemmings R., Bissonnette F., and Tan S. Effects of pretreatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin-releasing hormone analogues and on subsequent pregnancy rates. Fertil Steril 70 (1998) 1063-1069
48. Lindheim S., Barad D., Witt B., Ditkoff E., and Sauer M. Short-term gonadotrophin suppression with oral contraceptives benefits poor responders prior to controlled ovarian hyperstimulation. J Assist Reprod Genet 16 (1996) 745-747
49. Al-Mizyen E., Sabatini L., Lower A.M., Wilson C.M.Y., Al-Shawaf T., and Grudzinskas J.G. Does pretreatment with progestogen or oral contraceptive pills in low responders followed by the GnRHa flare protocol improve the outcome of IVF-ET?. J Assist Reprod Genet 17 (2000) 140-146
50. Leondires M.P., Escalpes M., Segars J.H., Scott R.T., and Miller B.T. Microdose follicular phase gonadotropin-releasing hormone agonists (GnRH-a) compared with luteal phase GnRH-a for ovarian stimulation at in vitro fertilization. Fertil Steril 72 (1999) 1018-1023
51. Cédrin-Durnerin I., Bulwa S., Herve F., Martin-Pont B., Uzan M., and Hugues J. The hormonal flare-up following gonadotropin-releasing hormone agonist administration is influenced by a progestogen pretreatment. Hum Reprod 11 (1996) 1859-1863
52. Kotarba D, Kotarba J, Hughes E. Growth hormone for in vitro fertilization (Cochrane Review). In: The Cochrane Library, 1: Update Software. Oxford: The Cochrane Collaboration; 2002.
53. Tesarik J., Hazout A., and Mendoza C. Improvement of delivery and live birth rates after ICSI in women aged > 40 years by ovarian co-stimulation with growth hormone. Hum Reprod 20 (2005) 2536-2541
54. Rombauts L., Suikkari A.M., MacLachlan V., Trounson A.O., and Healy D.L. Recruitment of follicles by recombinant human follicle-stimulating hormone commencing in the luteal phase of the ovarian cycle. Fertil Steril 69 (1998) 665-669
55. Lok I.H., Yip S.K., Cheung L.P., Yin Leung P.H., and Haines C.J. Adjuvant low-dose aspirin therapy in poor responders undergoing in v itro fertilization: a prospective, randomized, double-blind, placebo-controlled trial. Fertil Steril 81 (2004) 556-561
56. Battaglia C., Salvatori M., Maxia N., Petraglia F., Facchinetti F., and Volpe A. Adjuvant L-arginine treatment for in-vitro fertilization in poor responder patients. Hum reprod 14 (1999) 1690-1716
57. Fabregues F., Creus M., Penarrubia J., Manau D., Vanrell J.A., and Balasch J. Effects of recombinant human luteinizing hormone supplementation on ovarian stimulation and the implantation rate in down-regulated women of advanced age. Fertil Steril 85 (2006) 925-931
58. Loutradis D., Drakakis P., Vomvolaki E., and Antsaklis A. Different ovarian stimulation for women with diminished ovarian reserve. J Assist Reprod Genet 24 (2007) 597-611
59. Mohamed K.A., Davies W.A.R., Allsopp J., and Lashen H. Agonist flare-up versus antagonist in the management of poor responders undergoing in vitro fertilization treatment. Fertil Steril 83 (2005) 331-335
60. Copperman A.B. Antagonists in poor responders patients. Fertil Steril 80 (2003) S16-24
61. Marci R., Caserta D., Dolo V., Tatone C., Pavan A., and Moscarini M. GnRH antagonist in IVF poor-responder patients: results of a randomized trial. Reprod Biomed Online 11 (2005) 189-193
62. Akman M.A., Erden H.F., Tosun S.B., Bayazit N., Aksoy E., and Bahceci M. Comparison of agonistic flare-up protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trial. Hum Reprod 16 (2001) 868-870
63. Cheung L.P., Lam P.M., Lok I.H., Chiu T.T., Yeung S.Y., Tjer C.C., et al. GnRH antagonist versus long GnRH agonist protocol in poor responders undergoing IVF: a randomized controlled trial. Hum Reprod 20 (2005) 616-621
64. Griesinger G., Diedrich K., Tarlatzis B.C., and Kolibianakis E.M. GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis. Reprod Biomed Online 13 (2006) 628-638
65. De Placido G., Mollo A., Clarizia R., Strina I., Conforti S., and Alviggi C. Gonadotropin-releasing hormone (GnRH) antagonist plus recombinant luteinizing hormone vs. a standard GnRH agonist short protocol in patients at risk for poor response. Fertil Steril 85 (2006) 247-250
66. Chung K., Krey L., Katz J., and Noyes N. Evaluating the role of exogenous luteinizing hormone in poor responders undergoing in vitro fertilization with gonadotropin-releasing hormone antagonists. Fertil Steril 84 (2005) 313-318
67. Humaidan P., Bungum L., Bungum M., Hald F., Agerholm I., Blaabjerg J., et al. Reproductive outcome using a GnRH antagonist (cetrorelix) for luteolysis and follicular synchronization in poor responder IVF/ICSI patients treated with a flexible GnRH antagonist protocol. Reprod Biomed Online 11 (2005) 679-684
68. Bendikson K., Milki A.A., Speck-Zulak A., and Westpha L.M. Comparison of GnRH antagonist cycles with and without oral contraceptive pre-treatment in potential poor prognosis patients. Clin Exp Obstet Gynecol 33 (2006) 145-147
69. Dragisic K.G., Davis O.K., Fasouliotis S.J., and Rosenwaks Z. Use of a luteal estradiol patch and a gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation for in vitro fertilization in poor responders. Fertil Steril 84 (2005) 1023-1026
70. Franco J.R., Baruffi R.L.R., Mauri A.L., Petersen C.G., Felipe V., Cornicelli J., et al. GnRH agonist versus GnRH antagonist in poor ovarian responders: a meta-analysis. Reprod Biomed Online 13 (2006) 618-627
71. Casson P.R., Lindsay M.S., Pisarska M.D., Carson S.A., and Buster J.E. Dehydroepiandrosterone supplementation augments ovarian stimulation in poor responders : a case series. Hum Reprod 15 (2000) 2129-2132
72. Barad D., Brill H., and Gleicher N. Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function. J Assist Reprod Genet 24 (2007) 629-634
73. Massin N., Cédrin-Durnerin I., Coussieu C., Galey-Fontaine J., Wolf J.P., and Hugues J.N. Effects of transdermal testosterone application on the ovarian response to FSH in poor responders undergoing assisted reproduction technique - a prospective, randomized, double-blind study. Hum Reprod 21 (2006) 1204-1211
74. Toner J.P. Age = egg quality, FSH level = egg quantity. Fertil Steril 79 (2003) 491
75. Toner J.P. Ovarian reserve, female age and the chance for successful pregnancy. Minerva Ginecol 55 (2003) 399-406
76. Galey-Fontaine J., Cedrin-Durnerin I., Chaibi R., Massin N., and Hugues J.N. Age and ovarian reserve are distinct predictive factors of cycle outcome in low responders. Reprod Biomed Online 10 (2005) 94-99
77. Gleicher N., and Barad D. "Ovarian age-based" stimulation of young women with diminished ovarian reserve results in excellent pregnancy rates with in vitro fertilization. Fertil Steril 86 (2006) 1621-1625
78. Penarrubia J., Balasch J., Fabregues F., Carmona F., Casamitjana R., Moreo V., et al. Day 5 inhibin B concentrations as predictors of assisted reproductive technology outcome in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatment. Hum Reprod 15 (2000) 1499-1504
79. El-Toukhy T., Khalaf Y., Hart R., Taylor A., and Braude P. Young age does not protect against the adverse effects of reduced ovarian reserve - an eight year study. Hum Reprod 17 (2002) 1519-1524